Cited by 27Synthesis and biological activityFatty Acid Research and HealthCholesterol and Lipid Metabolism

Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid

Vu, Chi B., Bemis, Jean E., Benson, Ericka, Bista, Pradeep, Carney, David, Fahrner, Richard, Lee, Diana, Liu, Feng +11 more·2016·Journal of Medicinal Chemistry

Abstract

This report describes the synthesis and preliminary biological characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates. These molecular entities were created by covalently linking two bioactive molecules, either niacin or salicylic acid, to an omega-3 fatty acid. This methodology allows the simultaneous intracellular delivery of two bioactives in order to elicit a pharmacological response that could not be replicated by administering the bioactives individually or in combination. The fatty acid niacin conjugate 5 has been shown to be an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. On the other hand, the fatty acid salicylate conjugate 11 has been shown to have a unique anti-inflammatory profile based on its ability to modulate the NF-κB pathway through the intracellular release of the two bioactives.

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.5b01961

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The polypharmacological effect produced by simultaneous delivery of the starting chemical entities in a codrug is unique and cannot be replicated by administering multiple drugs in combinations.

    “Thus, the polypharmacological effect that can be produced by the simultaneous delivery of the starting chemical entities is unique and cannot be replicated by administering multiple drugs in combinations.84”
  • Codrugs can provide a high level of selectivity because the two molecules are rendered essentially inactive by covalent linking.

    “This process can provide a high level of selectivity because the two molecules are rendered essentially inactive by the covalent linking.84”
  • In codrugs, the two starting chemical entities are combined via a cleavable linker that, after enzymatic biotransformation, allows their release and individual biological effects against multiple pathways in the same target cells and at the same time.

    “In fact, in codrugs the two starting chemical entities are combined via a cleavable linker, which, only after enzymatic biotransformation, allows their release and their individual biological effects against multiple pathways, in the same target cells and at the same time.84”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vu, C. B., Bemis, J. E., Benson, E., Bista, P., Carney, D., Fahrner, R., Lee, D., Liu, F., Lonkar, P., Milne, J. C., Nichols, A. J., Picarella, D., Shoelson, A., Smith, J., Ting, A., Wensley, A., Yeager, M., Zimmer, M., & Jirousek, M. R.
Affiliations
Catabasis Pharmaceuticals (United States) (US)
Corresponding author
Vu, Chi B.
Venue
Journal of Medicinal Chemistry
Published
2016-02-01
Volume
59
Issue
3
Pages
1217-1231
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2257694034
Cited by
27
References
49
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 2
FWCI
1.22
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and biological activity
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
fatty acid conjugates, nicotinic acid, salicylic acid, omega-3 fatty acids, cholesterol metabolism, PCSK9, HMG-CoA reductase, ATP citrate lyase, NPC1L1, anti-inflammatory activity, NF-κB signaling, covalent conjugation
MeSH terms
Administration, Oral, Animals, Anti-Inflammatory Agents, Non-Steroidal, Cell Line, Dogs, Dose-Response Relationship, Drug, Fatty Acids, Humans, Hydrolysis, Liver, Niacin, Structure-Activity Relationship, Tissue Distribution, Molecular Structure, NF-kappa B, Rats, Sprague-Dawley, Salicylic Acid, Mice, Rats, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2, Hep G2 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review